Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
CCR2 单核细胞和 Mo-DC 在防御 IA 和 GVHD 发展中的作用
基本信息
- 批准号:8701013
- 负责人:
- 金额:$ 18.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAfrican AmericanAllogeneic Bone Marrow TransplantationAllogenicAntifungal AgentsAspergillosisBacteriaBiologicalBiologyBloodBlood CellsBone MarrowBone Marrow TransplantationCD4 Positive T LymphocytesCaucasiansCaucasoid RaceCellsDendritic CellsDevelopmentDiseaseHematologic NeoplasmsHereditary DiseaseHispanicsHistocompatibilityImmuneImmunityImpairmentInfectionInfection preventionInnovative TherapyKineticsKnowledgeLifeLinkMarrowMinorityModelingMonitorMouse StrainsMusMycosesOutcomePatientsPlayPredispositionPreventionProceduresProcessRegistriesRegulationRiskRoleShapesStagingStem cell transplantT cell responseT-Cell ReceptorT-LymphocyteTestingTransgenic MiceTransplantationUnited StatesVirusantimicrobialdesignfungusgraft vs host diseaseimprovedin vivoinsightmonocytenovelnovel therapeutic interventionpathogenpreventprogramsreconstitutionresponsesuccess
项目摘要
DESCRIPTION (provided by applicant): Allogeneic bone marrow transplantation (ABMT) can be a life-saving procedure as therapy against a variety of hematologic malignancies. The broad application of ABMT has been hampered by serious complications including life-threatening fungal infections (especially invasive aspergillosis, IA) and graft versus host disease (GVHD) development. The curative effects of ABMT could be more broadly exploited by ameliorating infection and GVHD side effects through novel therapeutic interventions. A detailed understanding of basic biological aspects of ABMT would facilitate the identification of relevant targets for the development of innovative therapies. In this application we seek to further our current knowledge of ABMT by examining the specific contributions of CCR2+ monocytes and monocyte-derived dendritic cells (Mo-DCs) in defense against fungal infection and in the development of GVHD. In the proposed studies we will test two main hypothesis: 1) monocytes prevent the development of IA after ABMT through direct antifungal effects and by playing non- redundant roles in maintaining T cell responses after ABMT, 2) Mo-DC influence the development of GVHD as donor and/or host derived DCs. The proposed studies will be made possible by employing novel mouse strains that facilitate the selective tracking and depletion of CCR2+ monocytes and Mo-DCs. We will also exploit our previously developed model for tracking the in vivo development of fungus-specific CD4 T cell responses to specifically examine the impact of ABMT and GVHD on the development of antifungal immunity. Altogether, the successful completion of the proposed studies would significantly advance our understanding of immune reconstitution after ABMT and illuminate previously unknown aspects of GVHD development. Moreover, we believe that our studies have the potential to uncover novel contributions of CCR2+ monocytes and derivate cells that could be exploited to prevent life-threatening fungal infections and GVHD development after ABMT.
描述(由申请人提供):同种异体骨髓移植(ABMT)可以是一种挽救生命的程序,作为针对各种血液学恶性肿瘤的治疗。严重的并发症(包括威胁生命的真菌感染(尤其是侵袭性曲霉菌病,IA),IA)和移植物与宿主疾病(GVHD)发育(GVHD)发育,阻碍了ABMT的广泛应用。通过新颖的治疗干预措施改善感染和GVHD副作用,可以更广泛地利用ABMT的治愈作用。对ABMT的基本生物学方面的详细理解将有助于识别相关的创新疗法的靶标。在此应用中,我们试图通过研究CCR2+单核细胞和单核细胞衍生的树突状细胞(MO-DC)在防御真菌感染和GVHD发展中的特定贡献,以进一步进一步了解ABMT的知识。在拟议的研究中,我们将检验两个主要假设:1)单核细胞通过直接抗真菌效应和通过在ABMT后保持T细胞反应中发挥非冗余作用来阻止ABMT后IA的发展,2)MO-DC影响GVHD作为供体和/或宿主的DCS的发展。提出的研究将通过采用新型的小鼠菌株来促进CCR2+单核细胞和MO-DC的选择性跟踪和耗竭。我们还将利用我们先前开发的模型,用于跟踪真菌特异性CD4 T细胞反应的体内开发,以专门检查ABMT和GVHD对抗真菌免疫发展的影响。总而言之,拟议研究的成功完成将大大提高我们对ABMT和阐明GVHD开发方面未知方面的免疫重建的理解。此外,我们认为我们的研究有可能发现CCR2+单核细胞的新贡献,并衍生出可以利用的细胞,以防止ABMT后威胁生命的真菌感染和GVHD发育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amariliz Rivera其他文献
Amariliz Rivera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amariliz Rivera', 18)}}的其他基金
Trained immunity and the regulation of anti-fungal defense
训练有素的免疫力和抗真菌防御的调节
- 批准号:
10557883 - 财政年份:2022
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10793773 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10574561 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10542652 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10097978 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10335166 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
9886185 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection
疫苗预防艾滋病相关隐球菌感染的机制
- 批准号:
10274411 - 财政年份:2019
- 资助金额:
$ 18.23万 - 项目类别:
Regulation of antifungal immunity by monocyte-derived dendritic cells
单核细胞来源的树突状细胞抗真菌免疫的调节
- 批准号:
9263884 - 财政年份:2015
- 资助金额:
$ 18.23万 - 项目类别:
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
CCR2 单核细胞和 Mo-DC 在防御 IA 和 GVHD 发展中的作用
- 批准号:
8637016 - 财政年份:2013
- 资助金额:
$ 18.23万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
- 批准号:
10822651 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别:
HER1-3 and Death Receptor protein folding as therapeutic vulnerabilities
HER1-3 和死亡受体蛋白折叠作为治疗漏洞
- 批准号:
10721930 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别:
Investigating microbiota of the gut-brain axis and the impact of cocaine
研究肠脑轴的微生物群和可卡因的影响
- 批准号:
10625082 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别:
The impact of structural racism and discrimination on chronic pain in Black or African American older adults: Biopsychosocial mechanisms
结构性种族主义和歧视对黑人或非裔美国老年人慢性疼痛的影响:生物心理社会机制
- 批准号:
10635199 - 财政年份:2023
- 资助金额:
$ 18.23万 - 项目类别: